Skriver, Signe Korsgaard http://orcid.org/0000-0003-1895-0963
Jensen, Maj-Britt
Eriksen, Jens-Ole
Ahlborn, Lise Barlebo
Knoop, Ann Soegaard
Rossing, Maria
Ejlertsen, Bent
Laenkholm, Anne-Vibeke
Funding for this research was provided by:
Kræftens Bekæmpelse (R146-A9562)
Harboefonden
Københavns Universitets fond for kræftforskning
Sejer Persson og Lis Klüvers legat
Article History
Received: 28 May 2020
Accepted: 22 July 2020
First Online: 3 August 2020
Compliance with ethical standards
:
: SKS declares she has no conflict of interest. MBJ has received institutional grants from Nanostring Technologies Inc and Oncology Venture. JOE declares he has no conflict of interest none, LBA declares she has no conflict of interest, ASK has received an institutional grant from Roche and is on advisory board for: Novartis, Astra Zeneca, MDS, Roche, Pfizer and ELI LILLY DANMARK A/S. MR is on advisory board for Astra Zeneca, BE has received institutional grants from: Nanostring Technologies Inc, Novartis and Roche. AVL has received research grants from Nanostring Technologies Inc. and Roche.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study is registered on clinicaltrials.gov (NCT00908531). The Biomedical Research Ethics of the Danish Capital Region approved the protocol (H-15012740). The genomic investigations presented here were subsequently approved (H-16031391).
: Informed consent was obtained from all individual participants included in the study.